Ocular photo-bio-stimulation optics
The invention addresses the limitations of existing ocular photo-bio-stimulation by targeting the entire retina with specific wavelengths to stimulate rods and ganglion cells, enhancing dopamine production and reducing pain, effectively treating conditions like myopia and ADHD with a cosmetically appealing design.
Patent Information
- Application Number
- AU2026254045
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-19
- Filing Date
- 2026-10-19
- Publication Date
- 2026-11-05
AI Technical Summary
Existing ocular photo-bio-stimulation technologies fail to effectively stimulate specific areas of the retina, such as the mid and far peripheral regions, and lack a cosmetically appealing design, while also not maximizing the number of melanopsin ganglion cells and rods stimulated.
The invention provides targeted light stimulation to the entire retina, including peripheral regions, using specific wavelengths to stimulate rods, ganglion cells, and cones, with a focus on increasing dopamine production and reducing pain, through the use of electronic displays and optics that are cosmetically desirable.
The solution achieves comprehensive retina stimulation, enhances dopamine production, reduces pain, and addresses conditions like myopia, ADHD, and other neurological disorders, while maintaining a discreet and aesthetically pleasing design.
Smart Images
Figure 00000153_0000 
Figure 00000154_0000 
Figure 00000155_0000